Research graph
References from A simplified protein precipitation-based LC–MS/MS workflow for legacy and emerging PFAS determination in serum and whole blood. Local targets link to admitted publications; unresolved targets remain external evidence.
Toxicology of perfluorinated compounds
10.1186/2190-4715-23-38 · 2011 · External reference
Physicochemical properties and interactions of perfluoroalkyl substances (PFAS) - challenges and opportunities in sensing and remediation
10.1016/j.scitotenv.2023.166764 · 2023 · External reference
A green analytical method for the simultaneous determination of 17 perfluoroalkyl substances (PFAS) in human serum and semen by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)
10.1016/j.jpba.2024.116203 · 2024 · External reference
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
10.1039/d0em00291g · 2020 · External reference
A never-ending story of per- and polyfluoroalkyl substances (PFASs)?
10.1021/acs.est.6b04806 · 2017 · External reference
The high persistence of PFAS is sufficient for their management as a chemical class
10.1039/d0em00355g · 2020 · External reference
Exposure of free-ranging white-tailed deer (Odocoileus virginianus) to per- and polyfluoroalkyl substances (PFAS) at PFAS-impacted sites in Minnesota
10.1016/j.chemosphere.2025.144642 · 2025 · External reference
Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany
10.1007/s00204-024-03843-x · 2024 · External reference
Per- and polyfluoroalkyl substances in China’s wastewater, surface water, and groundwater: occurrence characteristics, spatiotemporal distribution, and risk assessment
10.1007/s10653-025-02939-2 · 2026 · External reference
PFAS: forever chemicals—persistent, bioaccumulative and mobile. Reviewing the status and the need for their phase out and remediation of contaminated sites
2023 · External reference
The discovery and analysis of PFAS (‘Forever Chemicals’) in Human blood and biological materials
10.36253/substantia-2377 · 2024 · External reference
Health risks of dietary exposure to perfluorinated compounds
10.1016/j.envint.2011.08.001 · 2012 · External reference
Per-and polyfluoroalkyl substances (Pfas): significance and considerations within the regulatory framework of the USA
10.3390/ijerph182111142 · 2021 · External reference
Legacy and emerging per-and polyfluoroalkyl substances: analytical techniques, environmental fate, and health effects
10.3390/ijms22030995 · 2021 · External reference
Perfluorinated chemicals in relation to other persistent organic pollutants in human blood
10.1016/j.chemosphere.2005.11.040 · 2006 · External reference
10.3390/toxics9030063
10.3390/toxics9030063 · External reference
A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs)
10.1016/j.scitotenv.2018.04.380 · 2018 · External reference
Thyroid disrupting effects of old and new generation PFAS
10.3389/fendo.2020.612320 · 2021 · External reference
The interference between effects of PFAS exposure on thyroid hormone disorders and cholesterol levels: an NHANES analysis
10.1007/s11356-023-28739-8 · 2023 · External reference
Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight
10.1038/s41390-019-0720-1 · 2020 · External reference
Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: a systematic review and meta-analysis
10.1016/j.envres.2021.111632 · 2021 · External reference
Association between exposure to per- and perfluoroalkyl substances (PFAS) and reproductive hormones in human: a systematic review and meta-analysis
10.1016/j.envres.2023.117553 · 2024 · External reference
Per- and polyfluoroalkyl substances (PFAS) and miscarriage: the Norwegian mother, father and child cohort study
10.1016/j.envres.2026.124276 · 2026 · External reference
The effects of perfluoroalkyl and polyfluoroalkyl substances on female fertility: a systematic review and meta-analysis
10.1016/j.envres.2022.114718 · 2023 · External reference
Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances
10.1016/j.envint.2023.107734 · 2023 · External reference
Public health risks of PFAS-related immunotoxicity are real
10.1007/s40572-024-00441-y · 2024 · External reference
Critical review on PFOA, kidney cancer, and testicular cancer
10.1080/10962247.2021.1909668 · 2021 · External reference
Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis
10.1289/ehp.1205829 · 2013 · External reference
Unresolved reference
External reference
Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions
10.1016/j.envint.2014.11.013 · 2015 · External reference
Perfluorooctanoic acid (PFOA)-main concerns and regulatory developments in Europe from an environmental point of view
10.1186/2190-4715-24-16 · 2012 · External reference
Analytical methods employed in the identification and quantification of per- and polyfluoroalkyl substances in human matrices - A scoping review
10.1016/j.chemosphere.2023.140433 · 2023 · External reference
A sensitive and robust method for the simultaneous determination of thirty-three legacy and emerging per- and polyfluoroalkyl substances in human plasma and serum
10.1007/s00216-022-04426-4 · 2023 · External reference
Techniques to characterize PFAS burden in biological samples: recent insights and remaining challenges
10.1016/j.teac.2023.e00224 · 2024 · External reference
Self-collection blood test for PFASs: comparing volumetric microsamplers with a traditional serum approach
10.1021/acs.est.2c09852 · 2023 · External reference
Partition of perfluoroalkyl substances (PFASs) in whole blood and plasma, assessed in maternal and umbilical cord samples from inhabitants of arctic Russia and Uzbekistan
10.1016/j.scitotenv.2013.01.029 · 2013 · External reference
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals
10.1016/j.envres.2006.06.008 · 2007 · External reference
Distribution of novel and well-known poly- and perfluoroalkyl substances (PFASs) in Human serum, plasma, and whole blood
10.1021/acs.est.7b03299 · 2017 · External reference
Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada
10.1016/j.envpol.2019.03.054 · 2019 · External reference
Poly- and perfluoroalkyl substances in maternal serum: method development and application in Pilot Study of the Japan Environment and Children’s Study
10.1016/j.chroma.2020.460933 · 2020 · External reference
Refined SPE–LC–MS/MS method for simultaneous quantification of legacy PFAS in Korean population serum under volume-limited conditions
10.1016/j.jchromb.2026.125096 · 2026 · External reference
Determination of polyfluoroalkyl substances in biological matrices by chromatography techniques: a review focused on the sample preparation techniques - review
2023 · External reference
Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011
10.1016/j.envint.2013.07.013 · 2013 · External reference
Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry
10.1016/j.jchromb.2011.01.037 · 2011 · External reference
Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: implications for risk assessment
10.1016/j.envint.2016.10.008 · 2016 · External reference
A rapid and simple method to quantify per- and polyfluoroalkyl substances (PFAS) in plasma and serum using 96-well plates
10.1016/j.mex.2020.101111 · 2020 · External reference
Human biomonitoring of persistent and non-persistent pollutants in a representative sample of the general population from Cape Verde: results from the PERVEMAC-II study
10.1016/j.envpol.2022.119331 · 2022 · External reference
Gestational exposure to organophosphate pesticides and maternal urine metabolomic profile in the GENEIDA birth cohort
10.1016/j.etap.2025.104793 · 2025 · External reference
Unresolved reference
External reference
Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality
10.1039/d3gc02347h · 2023 · External reference
A tutorial on AGREEprep an analytical greenness metric for sample preparation
2022 · External reference
Red analytical performance index (RAPI) and software: the missing tool for assessing methods in terms of analytical performance
10.1039/d4gc05298f · 2025 · External reference
Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study
10.1186/s12940-024-01085-z · 2024 · External reference
Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999–March 2020
10.1016/j.envres.2025.120916 · 2025 · External reference
Organofluorine mass balance analysis of whole blood samples in relation to gender and age
2021 · External reference
Analytical method interferences for perfluoropentanoic acid (PFPeA) and perfluorobutanoic acid (PFBA) in biological and environmental samples
10.1016/j.chemosphere.2022.137722 · 2023 · External reference
PFAS ghosts: how to identify, evaluate, and exorcise new and existing analytical interference
10.1007/s00216-024-05125-y · 2024 · External reference
Development of an LC-MS/MS method for the simultaneous quantification of 11 perfluoroalkyl compounds in mouse plasma for toxicokinetic applications
10.1016/j.jpba.2024.116596 · 2025 · External reference
Branched perfluorooctane sulfonate isomer quantification and characterization in blood serum samples by HPLC/ESI-MS(/MS)
10.1021/es901261v · 2009 · External reference
Analysis of perfluoroalkyl and polyfluoroalkyl substances in serum and plasma by solvent precipitation-isotope dilution-direct injection-LC/MS/MS
10.1039/c6ay02809h · 2017 · External reference
Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations
10.1016/j.chemosphere.2012.03.049 · 2012 · External reference
A simple and rapid method for quantitative HPLC MS/MS determination of selected perfluorocarboxylic acids and perfluorosulfonates in Human serum
10.1155/2020/8878618 · 2020 · External reference
Evaluation and validation of methodologies for the extraction of per- and polyfluoroalkyl substances (PFASs) in serum of birds and mammals
10.1007/s00216-022-03962-3 · 2022 · External reference
Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4
10.1007/s00216-021-03762-1 · 2022 · External reference
Comparison of extraction methods for per- and polyfluoroalkyl substances (PFAS) in human serum and placenta samples—insights into extractable organic fluorine (EOF)
10.1007/s00216-020-03041-5 · 2021 · External reference
Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry
10.1007/s00216-019-02263-6 · 2020 · External reference
Sensitive and accurate determination of 32 PFAS in human serum using online SPE-UHPLC-HRMS
10.1016/j.jhazmat.2024.136780 · 2025 · External reference
A novel automated micro solid phase extraction (µSPE) method to quantify 21 per- and polyfluoroalkyl substances compounds in biological samples
2026 · External reference
Integration of ultrashort-chain compounds into the biomonitoring of per- and polyfluorinated substances in human plasma and serum
2024 · External reference
Direct analysis of per- and polyfluoroalkyl substances (PFAS) in plasma by liquid chromatography coupled to mass spectrometry (LC–MS) for biomonitoring purposes
10.1007/s12403-026-00763-2 · 2026 · External reference
Development of a solid-phase extraction-HPLC/single quadrupole MS method for quantification of perfluorochemicals in whole blood
10.1021/ac049023c · 2005 · External reference
An analytical method for the determination of perfluorinated compounds in whole blood using acetonitrile and solid phase extraction methods
10.1016/j.chroma.2009.04.070 · 2009 · External reference
Analysis of perfluoroalkyl substances in cord blood by turbulent flow chromatography coupled to tandem mass spectrometry
10.1016/j.scitotenv.2012.05.080 · 2012 · External reference
Trace analysis of per- and polyfluorinated alkyl substances (PFAS) in dried blood spots – demonstration of reproducibility and comparability to venous blood samples
10.1016/j.scitotenv.2023.163530 · 2023 · External reference
Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots
10.1007/s00216-024-05484-6 · 2024 · External reference
Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood
10.1016/j.chroma.2023.464522 · 2024 · External reference
Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany
10.1007/s00204-024-03843-x · ExternalCitation · doi-reference
Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry
10.1007/s00216-019-02263-6 · ExternalCitation · doi-reference
Comparison of extraction methods for per- and polyfluoroalkyl substances (PFAS) in human serum and placenta samples—insights into extractable organic fluorine (EOF)
10.1007/s00216-020-03041-5 · ExternalCitation · doi-reference
Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4
10.1007/s00216-021-03762-1 · ExternalCitation · doi-reference
Evaluation and validation of methodologies for the extraction of per- and polyfluoroalkyl substances (PFASs) in serum of birds and mammals
10.1007/s00216-022-03962-3 · ExternalCitation · doi-reference
A sensitive and robust method for the simultaneous determination of thirty-three legacy and emerging per- and polyfluoroalkyl substances in human plasma and serum
10.1007/s00216-022-04426-4 · ExternalCitation · doi-reference
PFAS ghosts: how to identify, evaluate, and exorcise new and existing analytical interference
10.1007/s00216-024-05125-y · ExternalCitation · doi-reference
Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots
10.1007/s00216-024-05484-6 · ExternalCitation · doi-reference
Per- and polyfluoroalkyl substances in China’s wastewater, surface water, and groundwater: occurrence characteristics, spatiotemporal distribution, and risk assessment
10.1007/s10653-025-02939-2 · ExternalCitation · doi-reference
The interference between effects of PFAS exposure on thyroid hormone disorders and cholesterol levels: an NHANES analysis
10.1007/s11356-023-28739-8 · ExternalCitation · doi-reference
Direct analysis of per- and polyfluoroalkyl substances (PFAS) in plasma by liquid chromatography coupled to mass spectrometry (LC–MS) for biomonitoring purposes
10.1007/s12403-026-00763-2 · ExternalCitation · doi-reference
Public health risks of PFAS-related immunotoxicity are real
10.1007/s40572-024-00441-y · ExternalCitation · doi-reference
Perfluorinated chemicals in relation to other persistent organic pollutants in human blood
10.1016/j.chemosphere.2005.11.040 · ExternalCitation · doi-reference
Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations
10.1016/j.chemosphere.2012.03.049 · ExternalCitation · doi-reference
Analytical method interferences for perfluoropentanoic acid (PFPeA) and perfluorobutanoic acid (PFBA) in biological and environmental samples
10.1016/j.chemosphere.2022.137722 · ExternalCitation · doi-reference
Analytical methods employed in the identification and quantification of per- and polyfluoroalkyl substances in human matrices - A scoping review
10.1016/j.chemosphere.2023.140433 · ExternalCitation · doi-reference
Exposure of free-ranging white-tailed deer (Odocoileus virginianus) to per- and polyfluoroalkyl substances (PFAS) at PFAS-impacted sites in Minnesota
10.1016/j.chemosphere.2025.144642 · ExternalCitation · doi-reference
An analytical method for the determination of perfluorinated compounds in whole blood using acetonitrile and solid phase extraction methods
10.1016/j.chroma.2009.04.070 · ExternalCitation · doi-reference
Poly- and perfluoroalkyl substances in maternal serum: method development and application in Pilot Study of the Japan Environment and Children’s Study
10.1016/j.chroma.2020.460933 · ExternalCitation · doi-reference
Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood
10.1016/j.chroma.2023.464522 · ExternalCitation · doi-reference
Health risks of dietary exposure to perfluorinated compounds
10.1016/j.envint.2011.08.001 · ExternalCitation · doi-reference
Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011
10.1016/j.envint.2013.07.013 · ExternalCitation · doi-reference
Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions
10.1016/j.envint.2014.11.013 · ExternalCitation · doi-reference
Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: implications for risk assessment
10.1016/j.envint.2016.10.008 · ExternalCitation · doi-reference
Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances
10.1016/j.envint.2023.107734 · ExternalCitation · doi-reference
Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada
10.1016/j.envpol.2019.03.054 · ExternalCitation · doi-reference
Human biomonitoring of persistent and non-persistent pollutants in a representative sample of the general population from Cape Verde: results from the PERVEMAC-II study
10.1016/j.envpol.2022.119331 · ExternalCitation · doi-reference
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals
10.1016/j.envres.2006.06.008 · ExternalCitation · doi-reference
Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: a systematic review and meta-analysis
10.1016/j.envres.2021.111632 · ExternalCitation · doi-reference
The effects of perfluoroalkyl and polyfluoroalkyl substances on female fertility: a systematic review and meta-analysis
10.1016/j.envres.2022.114718 · ExternalCitation · doi-reference
Association between exposure to per- and perfluoroalkyl substances (PFAS) and reproductive hormones in human: a systematic review and meta-analysis
10.1016/j.envres.2023.117553 · ExternalCitation · doi-reference
Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999–March 2020
10.1016/j.envres.2025.120916 · ExternalCitation · doi-reference
Per- and polyfluoroalkyl substances (PFAS) and miscarriage: the Norwegian mother, father and child cohort study
10.1016/j.envres.2026.124276 · ExternalCitation · doi-reference
Gestational exposure to organophosphate pesticides and maternal urine metabolomic profile in the GENEIDA birth cohort
10.1016/j.etap.2025.104793 · ExternalCitation · doi-reference
Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry
10.1016/j.jchromb.2011.01.037 · ExternalCitation · doi-reference
Refined SPE–LC–MS/MS method for simultaneous quantification of legacy PFAS in Korean population serum under volume-limited conditions
10.1016/j.jchromb.2026.125096 · ExternalCitation · doi-reference
Sensitive and accurate determination of 32 PFAS in human serum using online SPE-UHPLC-HRMS
10.1016/j.jhazmat.2024.136780 · ExternalCitation · doi-reference
A green analytical method for the simultaneous determination of 17 perfluoroalkyl substances (PFAS) in human serum and semen by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)
10.1016/j.jpba.2024.116203 · ExternalCitation · doi-reference
Development of an LC-MS/MS method for the simultaneous quantification of 11 perfluoroalkyl compounds in mouse plasma for toxicokinetic applications
10.1016/j.jpba.2024.116596 · ExternalCitation · doi-reference
A rapid and simple method to quantify per- and polyfluoroalkyl substances (PFAS) in plasma and serum using 96-well plates
10.1016/j.mex.2020.101111 · ExternalCitation · doi-reference
Analysis of perfluoroalkyl substances in cord blood by turbulent flow chromatography coupled to tandem mass spectrometry
10.1016/j.scitotenv.2012.05.080 · ExternalCitation · doi-reference
Partition of perfluoroalkyl substances (PFASs) in whole blood and plasma, assessed in maternal and umbilical cord samples from inhabitants of arctic Russia and Uzbekistan
10.1016/j.scitotenv.2013.01.029 · ExternalCitation · doi-reference
A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs)
10.1016/j.scitotenv.2018.04.380 · ExternalCitation · doi-reference
Trace analysis of per- and polyfluorinated alkyl substances (PFAS) in dried blood spots – demonstration of reproducibility and comparability to venous blood samples
10.1016/j.scitotenv.2023.163530 · ExternalCitation · doi-reference
Physicochemical properties and interactions of perfluoroalkyl substances (PFAS) - challenges and opportunities in sensing and remediation
10.1016/j.scitotenv.2023.166764 · ExternalCitation · doi-reference
Techniques to characterize PFAS burden in biological samples: recent insights and remaining challenges
10.1016/j.teac.2023.e00224 · ExternalCitation · doi-reference
Development of a solid-phase extraction-HPLC/single quadrupole MS method for quantification of perfluorochemicals in whole blood
10.1021/ac049023c · ExternalCitation · doi-reference
Self-collection blood test for PFASs: comparing volumetric microsamplers with a traditional serum approach
10.1021/acs.est.2c09852 · ExternalCitation · doi-reference
A never-ending story of per- and polyfluoroalkyl substances (PFASs)?
10.1021/acs.est.6b04806 · ExternalCitation · doi-reference
Distribution of novel and well-known poly- and perfluoroalkyl substances (PFASs) in Human serum, plasma, and whole blood
10.1021/acs.est.7b03299 · ExternalCitation · doi-reference
Branched perfluorooctane sulfonate isomer quantification and characterization in blood serum samples by HPLC/ESI-MS(/MS)
10.1021/es901261v · ExternalCitation · doi-reference
Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight
10.1038/s41390-019-0720-1 · ExternalCitation · doi-reference
Analysis of perfluoroalkyl and polyfluoroalkyl substances in serum and plasma by solvent precipitation-isotope dilution-direct injection-LC/MS/MS
10.1039/c6ay02809h · ExternalCitation · doi-reference
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
10.1039/d0em00291g · ExternalCitation · doi-reference
The high persistence of PFAS is sufficient for their management as a chemical class
10.1039/d0em00355g · ExternalCitation · doi-reference
Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality
10.1039/d3gc02347h · ExternalCitation · doi-reference
Red analytical performance index (RAPI) and software: the missing tool for assessing methods in terms of analytical performance
10.1039/d4gc05298f · ExternalCitation · doi-reference
Critical review on PFOA, kidney cancer, and testicular cancer
10.1080/10962247.2021.1909668 · ExternalCitation · doi-reference
A simple and rapid method for quantitative HPLC MS/MS determination of selected perfluorocarboxylic acids and perfluorosulfonates in Human serum
10.1155/2020/8878618 · ExternalCitation · doi-reference
Toxicology of perfluorinated compounds
10.1186/2190-4715-23-38 · ExternalCitation · doi-reference
Perfluorooctanoic acid (PFOA)-main concerns and regulatory developments in Europe from an environmental point of view
10.1186/2190-4715-24-16 · ExternalCitation · doi-reference
Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study
10.1186/s12940-024-01085-z · ExternalCitation · doi-reference
Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis
10.1289/ehp.1205829 · ExternalCitation · doi-reference
Thyroid disrupting effects of old and new generation PFAS
10.3389/fendo.2020.612320 · ExternalCitation · doi-reference
Per-and polyfluoroalkyl substances (Pfas): significance and considerations within the regulatory framework of the USA
10.3390/ijerph182111142 · ExternalCitation · doi-reference
Legacy and emerging per-and polyfluoroalkyl substances: analytical techniques, environmental fate, and health effects
10.3390/ijms22030995 · ExternalCitation · doi-reference
10.3390/toxics9030063
10.3390/toxics9030063 · ExternalCitation · doi-reference
The discovery and analysis of PFAS (‘Forever Chemicals’) in Human blood and biological materials
10.36253/substantia-2377 · ExternalCitation · doi-reference
